Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

COX-2 inhibitors for colorectal cancer

Nature Medicine volume 4, pages392–393(1998)Cite this article

COX-2 selective non-steroidal anti-inflammatory drugs show promise in the prevention of coiorectal cancer and possibly other tumors.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

Rent or Buy

All prices are NET prices.

References

  1. 1

    Shift, S.J. & Rigas, B. Nonsteroidal antiinflamma-tory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113 1992–1998 (1997).

    Article  Google Scholar 

  2. 2

    Kawamori, T., Rao, C.V., Seibert, K. & Reddy, B.S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58, 409–412 (1998).

    CAS  PubMed  Google Scholar 

  3. 3

    Williams, C.S. & DuBois, R.N. Prostaglandin endoperoxide synthase: Why two isoforms? Am. J. Physiol 270, G393–G400 (1996).

    CAS  PubMed  Google Scholar 

  4. 4

    Oshima, M. et al. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803–809 (1996).

    CAS  Article  Google Scholar 

  5. 5

    Sheng, H., Shao, J., Morrow, J.D., Beauchamp, R.D. & DuBois, R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58, 362–366 (1998).

    CAS  PubMed  Google Scholar 

  6. 6

    Chan, T.A., Morin, P.J., Vogelstein, B. & Kinzler, K.W. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA 95, 681–686 (1998).

    CAS  Article  Google Scholar 

  7. 7

    Piazza, G.A. et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 57, 2909–2915 (1997).

    CAS  PubMed  Google Scholar 

  8. 8

    Elder, D.J.E., Halton, D.E., Hague, A. & Paraskeva, C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Can. Res. 3, 1679–1683 (1997).

    CAS  Google Scholar 

  9. 9

    Vane, J. Towards a better aspirin. Nature 367, 215–216 (1994).

    CAS  Article  Google Scholar 

  10. 10

    Hong, S.H. et al. Regulation of head and neck tumor cell growth with cyclooxygenase-2 specific inhibitor, ketorolac. Cancer Res. 39, 196 (1998).

    Google Scholar 

  11. 11

    Hwang, D. et al. Expression of cyclooxygenase in human breast cancer. Cancer Res. 39, 353 (1998).

Download references

Author information

Affiliations

  1. Department of Pathology and Microbiology, University of Bristol, Bristol, BS8 1TD, UK

    Douglas J. E. Elder & Christos Paraskeva

Authors
  1. Douglas J. E. Elder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christos Paraskeva
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Elder, D., Paraskeva, C. COX-2 inhibitors for colorectal cancer. Nat Med 4, 392–393 (1998). https://doi.org/10.1038/nm0498-392

Download citation

Further reading

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing